OncologyConsults




Lung CME
CME Activities

Considerations for Using Immune Therapy in Treating Metastatic Non-Small Cell Lung Cancer CME Credits: 0.5
Recent advances in immune therapy for patients with non-small cell lung cancer (NSCLC) have taken a long-awaited step forward and shifted the standard of care of patients with advanced and metastatic disease.
Faculty: David S. Ettinger, MD Expires: 11/19/2018